CRISPER/CAS System, a Novel Tool of Targeted Therapy of Drug-Resistant Lung Cancer

Vahid Akbari Kordkheyli ¹ , Mohsen Rashidi ², Yasaman Shokri ³, Samane Fallahpour ³, Atena Variji ³, Ehsan Nabipour Ghara ⁴, Sayed Mostafa Hosseini ⁵ *

Cited by CrossRef: 3

1- Mirabedini S, Musavi H, Makhlough A, Hashemi-Sooteh M, Zargari M. Association of S19W polymorphism in APOA5 gene and serum lipid levels in patients with type 2 diabetic nephropathy. 2023;44(3):243 [Crossref]

2- Zhang Z, Wang H, Yan Q, Cui J, Chen Y, Ruan S, Yang J, Wu Z, Han M, Huang S, Zhou Q, Zhang C, Hou B. Genome-wide CRISPR/Cas9 screening for drug resistance in tumors. Front Pharmacol. 2023;14 [Crossref]